Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001422848-25-000057·Capital Research Global Investors
Schedule 13G ownership disclosure
Haemonetics Corp
Common Stock · CUSIP: 405024100
Event date: 2025-03-31
- Filing-level shares
- 1,577,323.00
- Percent of class
- 3.1%
- Capital Research Global Investors
Shares: 1,577,323.00 · Class: 3.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-25-000057
- Form type
- SCHEDULE 13G/A
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Apr 04, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership